At Q2 Solutions, we offer the processing of peripheral blood mononuclear cells (PBMCs) and bone marrow mononuclear cells (BMMCs) at our central laboratories across the world. All our processes are performed to globally harmonized standards ensuring consistently high yields, viability and recovery.
Global PBMC Network - 24-Hour Global Transit Time Map
Rules-Based Medicine, a Q2 Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...
TruCulture from Rules-Based Medicine, a Q2 Solutions’ company, provides an innovative whole blood collection and culture system for clinical trials. TruCulture provides a standardized option that...
Multiple peer-reviewed publications have consistently demonstrated a set of blood-based protein biomarkers associated with idiopathic pulmonary fibrosis (IPF) disease progression. A set of...